Zileuton sodium is used as a potent and selective 5-lipoxygenase inhibitor with anti-inflammatory activity; it reduces IL-2 levels by inhibiting leukotriene B4 production; decreases NF-κB expression and apoptotic index in ischemia/reperfusion (I/R) rat models; inhibits polyp formation in the colon and small intestine of APCΔ468 mice; suppresses proliferation and enhances apoptosis of non-epithelial cells in polyps.